The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 receptor agonist. High-profile endorsements, including from Elon Musk, have ...